Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: ELIQUIS

« Back to Dashboard

Eliquis is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

The generic ingredient in ELIQUIS is apixaban. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the apixaban profile page.

Summary for Tradename: ELIQUIS

Suppliers: see list1

Pharmacology for Tradename: ELIQUIS

Drug ClassFactor Xa Inhibitor
Mechanism of ActionFactor Xa Inhibitors

Clinical Trials for: ELIQUIS

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
TABLET;ORAL202155Dec 28, 2012RXNo6,413,980<disabled>YY<disabled>
Bristol Myers Squibb
TABLET;ORAL202155Dec 28, 2012RXYes<disabled><disabled>
Bristol Myers Squibb
TABLET;ORAL202155Dec 28, 2012RXYes6,967,208<disabled>YY<disabled>
Bristol Myers Squibb
TABLET;ORAL202155Dec 28, 2012RXNo6,967,208<disabled>YY<disabled>
Bristol Myers Squibb
TABLET;ORAL202155Dec 28, 2012RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology